Companies / Medifast Inc

Medifast Inc

NYSE: MEDCIK 910329BALTIMORE, MDmedifast1.com ↗

Financials · FY2025

Revenue$385.79M
Net income$-18.67M
Total debt$0
Cash$71.91M
Diluted EPS$-1.70
Shares outstanding11.2M

Ownership

11.2M shares outstanding · as of Jul 27, 2026
2.5%Insiders
Ownership
Insiders2.52%282,104
10%+ / strategic13.87%1,550,539
Institutions53.14%5,941,218
Public float30.47%3,406,842

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Chard Daniel RCEOChairman & CEO · Director
1.68%188,233
Maloney James P.Chief Financial Officer
0.65%73,033
MacKenzie Jonathan BarrettVP, Finance & CAO
0.19%20,838
Johnson Nicholas MarkPresident
——

Institutional holders 110

View all →
HolderValue% of shares
Charles Schwab Investment Management Inc$8.30M6.95%
Renaissance Technologies LLC$7.88M6.92%
Vanguard Group Inc$7.60M6.36%
BlackRock, Inc.$3.92M3.30%
Morgan Stanley$3.58M2.99%
Dimensional Fund Advisors LP$3.48M2.92%
Two Sigma Investments, LP$3.45M3.02%
Steamboat Capital Partners, LLC$2.95M2.47%
Geode Capital Management, LLC$2.58M2.27%
Man Group plc$2.53M2.12%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 25, 2026Maloney James P.
Executive
OtherCommon Stock$30.9K-3K
-7.88%
37,675
0.34% of shares
low
Mar 13, 2026Maloney James P.
Executive
OtherCommon Stock$8.8K-918
-2.17%
41,381
0.37% of shares
low
Mar 25, 2026MacKenzie Jonathan Barrett
Executive
OtherCommon Stock$8.3K-862
-7.93%
10,008
0.09% of shares
low
Mar 17, 2026Maloney James P.
Executive
OtherCommon Stock$4.8K-482
-1.16%
40,899
0.37% of shares
low
Mar 13, 2026MacKenzie Jonathan Barrett
Executive
OtherCommon Stock$1.9K-198
-1.78%
10,940
0.10% of shares
low
Mar 17, 2026MacKenzie Jonathan Barrett
Executive
OtherCommon Stock$704-70
-0.64%
10,870
0.10% of shares
low
Mar 25, 2026MacKenzie Jonathan Barrett
Executive
GrantCommon Stock$0+11K
+108.21%
20,838
0.19% of shares
low
Mar 25, 2026Maloney James P.
Executive
GrantCommon Stock$0+1K
+1.41%
73,033
0.65% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Capital Ventures InternationalPassive13G/A———
Charles Schwab Investment Management IncPassive13G/A—776,829—
Renaissance Technologies LLCPassive13G/A—773,710—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MED——58470H101—